Eicosapentaenoic Acid Supplementation for Chronic Hepatitis C Patients During Combination Therapy of Pegylated Interferon α-2b and Ribavirin

By Kawashima Aiko  

Lipids, Vol. 43, Iss. 4, 2008-04 ,pp. : 325-333

Springer Publishing Company

Access to resources Recommend Favorite

Serum zinc as a factor predicting response to interferon-α2b therapy in children with chronic hepatitis B

By Özbal Ebru   Helvaci Mehmet   Kasirga Erhun   Akdenizoglu Figen   Kizilgüneşler Asli  

Biological Trace Element Research, Vol. 90, Iss. 1-3, 2002-12 ,pp. : 31-38

Humana Press, Inc

Access to resources Recommend Favorite

Insulin resistance is associated with DNA damage in peripheral blood cells in non-diabetic patients with genotype 1 chronic hepatitis C

By Sakae P. N.   Ihara S. S. M.   Ribeiro D. A.   de Carvalho L.   Parise E. R.  

Free Radical Research, Vol. 47, Iss. 9, 2013-09 ,pp. : 750-756

Informa Healthcare

Access to resources Recommend Favorite

Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C

By Scagnolari Carolina   Antonelli Guido  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-08 ,pp. : 693-711

Informa Healthcare

Access to resources Recommend Favorite

Influence of pegylated interferon-α therapy on plasma levels of citrulline and arginine in melanoma patients

By Fekkes D.   Bannink M.   Kruit W. H. J.   Van Gool A. R.   Mulder P. G. H.   Sleijfer S.   Eggermont A. M. M.   Stoter G.  

Amino Acids, Vol. 32, Iss. 1, 2007-01 ,pp. : 121-126

Springer Publishing Company

Access to resources Recommend Favorite